Heartflow Q2 revenue rises 48%, lifts 2026 outlook
HTFL•Result drivers
- U.S. CASE VOLUME - Co said year-over-year revenue growth was primarily driven by higher total U.S. FFR(CT) and Plaque revenue case volumes
- AI EFFICIENCY - Gross margin expansion attributed to increased case volume, higher U.S. Plaque revenue, and improved production team productivity from AI efficiency initiatives
- HIGHER OPERATING EXPENSES - Increase in operating expenses due to greater investment in sales personnel, technology, and clinical research
Updated 2026 outlook
- Heartflow raises 2026 revenue guidance to $246 mln-$250 mln from $228 mln-$232 mln
- Company lifts 2026 non-GAAP gross margin outlook to about 82% from about 81%
- Heartflow says CCTA market remains under-penetrated, supporting expectations for continued growth
Quarterly revenue and margin improve
- U.S. AI cardiovascular diagnostics firm's Q2 revenue rose 48% yr/yr on higher case volumes
- Company posted record gross margin of 83.0%, up from 75.5% a year ago
- Heartflow raised 2026 revenue guidance to 40-42% growth from prior 29-32% forecast
Key financial details and analyst coverage
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|
